Holen Sie sich die Stockscreener-App
3.87
1.31%
0.05
Schlusskurs vom Vortag:
$3.82
Offen:
$3.85
24-Stunden-Volumen:
62,658
Relative Volume:
0.71
Marktkapitalisierung:
$31.99M
Einnahmen:
$442.00K
Nettoeinkommen (Verlust:
$-30.46M
KGV:
-0.8677
EPS:
-4.46
Netto-Cashflow:
$-27.47M
1W Leistung:
+3.75%
1M Leistung:
-9.58%
6M Leistung:
-19.37%
1J Leistung:
-10.62%
1-Tages-Spanne:
$3.7969
$3.9899
1-Wochen-Bereich:
$3.63
$3.9899
52-Wochen-Spanne:
$2.2801
$6.96
Clene Inc Stock (CLNN) Company Profile
Firmenname
Clene Inc
Sektor
Branche
Telefon
801-676-9695
Adresse
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Vergleichen Sie CLNN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
3.87 | 33.51M | 442.00K | -30.46M | -27.47M | -4.46 |
|
KHC
Kraft Heinz Co
|
27.48 | 32.90B | 25.43B | 2.66B | 3.03B | 2.19 |
|
JBS
Jbs N V
|
13.05 | 28.90B | 88.95B | 2.16B | 374.50M | 0.9748 |
|
K
Kellanova
|
79.77 | 27.64B | 12.63B | 1.38B | 863.00M | 3.96 |
|
GIS
General Mills Inc
|
49.18 | 27.65B | 19.64B | 2.56B | 2.48B | 4.55 |
|
MKC
Mccormick Co Inc
|
70.74 | 19.31B | 6.68B | 792.60M | 774.40M | 2.94 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-10-04 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-07-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-05-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-09-28 | Eingeleitet | Oppenheimer | Outperform |
Clene Inc Aktie (CLNN) Neueste Nachrichten
What drives Clene Inc. Equity Warrant stock priceTremendous portfolio expansion - Autocar Professional
What analysts say about Clene Inc. stockFastest return on investment - Autocar Professional
Is Clene Inc. a good long term investmentFree Investment Community - Autocar Professional
Clene’s (CLNN) “Buy” Rating Reiterated at D. Boral Capital - Defense World
Is Clene Inc. Equity Warrant a good long term investmentOutstanding risk-reward balance - Autocar Professional
What analysts say about Clene Inc. Equity Warrant stockUnprecedented profit potential - Autocar Professional
Clene Inc. Stock Analysis and ForecastDynamic capital growth - jammulinksnews.com
Clene Inc. Equity Warrant Stock Analysis and ForecastFree Consultation - jammulinksnews.com
What drives Clene Inc. stock priceUnprecedented growth rates - jammulinksnews.com
What makes Clene Inc. stock attractive to long term investorsFree Access to Community - beatles.ru
Promising Nanotechnology Stocks To Watch Now – July 16th - Defense World
Promising Nanotechnology Stocks To Watch NowJuly 16th - MarketBeat
How Clene Inc. stock performs during market volatilityHigh Potential Shares - Newser
Why Clene Inc. stock attracts strong analyst attentionParabolic Move Ideas - Newser
How Clene Inc. Equity Warrant stock performs during market volatilityBalanced Risk Reward Portfolio - Newser
What makes Clene Inc. Equity Warrant stock price move sharplyFree Stock Market Practical Discussion Forums - Newser
What makes Clene Inc. stock price move sharply200 Percent Watchlist - Newser
Why Clene Inc. Equity Warrant stock attracts strong analyst attentionProfitable Yet Secure Picks - Newser
Best Nanotechnology Stocks Worth Watching – July 12th - Defense World
Promising Nanotechnology Stocks To Add to Your Watchlist – July 9th - Defense World
Promising Nanotechnology Stocks To Add to Your WatchlistJuly 9th - MarketBeat
Nanotechnology Stocks To Watch Today – July 7th - Defense World
Clene (NASDAQ: CLNN) to Conduct Neurofilament Biomarker Analysis for CNM-Au8(R) in ALS in Early Q4 2025 - Barchart.com
Clene Inc. (NASDAQ:CLNN) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Top Nanotechnology Stocks To Follow Today – July 5th - Defense World
Top Nanotechnology Stocks To Keep An Eye On – July 4th - Defense World
Nanotechnology Stocks To Research – July 3rd - Defense World
Clene working with FDA on accelerated approval for CNM-Au8 - ALS News Today
Clene files prospectus supplement for $2 million stock offering under existing agreement - Investing.com UK
Clene stock advances as FDA meetings approach for ALS treatment By Investing.com - Investing.com Nigeria
Clene stock maintains Buy rating at H.C. Wainwright on ALS drug progress - Investing.com India
Finanzdaten der Clene Inc-Aktie (CLNN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.63%
1.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):